Adults 18-75 years of age with chronic plaque psoriasis for at least 6 months, may qualify to participate. Eligible participants must have plaque psoriasis covering at least 10% of their body, with moderate to severe disease at the time of study entry.
Participants will receive investigational oral medication (active drug or placebo). Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.
Study participation will last up to 24 weeks and include about 11 visits to the study centre.
Email Tina Craig, Clincal Research Coordinator at DermEffects to register.